Breast Cancer Trials
Explore how clinical research is advancing treatment and discover studies that may be a match for your diagnosis and treatment history.
What are Breast Cancer trials?
Clinical trials are research studies involving people, designed to evaluate new treatments, drugs, procedures, or interventions tor safety, effectiveness, and potential advantages over current options.
Breast cancer clinical trials test emerging therapies, including targeted drugs, immunotherapy and precision medicine for both early-stage and metastatic disease. These studies help identify which treatments work best, who benefits most, and how they improve survival and quality of life.
Participation in a clinical trial often means contributing to progress in medicine while potentially gaining early access to innovative care.
CancerBot makes it easy for patients and clinicians to find clinical trials they are actually eligible for by analyzing trial criteria such as subtype (HER2-positive, TNBC, hormone-receptor positive), stage, biomarkers, and treatment history. Instead of manually searching long lists of studies, CancerBot filters and matches trials automatically.
Understanding Breast Cancer
Breast Cancer is the most common cancer in women worldwide and can also affect men. It occurs when abnormal cells in the breast tissue grow uncontrollably, forming a tumor.
While Breast Cancer is often detected early through screening, it can spread to nearby lymph nodes or other parts of the body if left untreated.
Advances in early detection and treatment have significantly improved outcomes in recent years.
Common symptoms
Early signs of Breast Cancer may vary, and not all symptoms are easily noticeable. Common symptoms include:
A lump or thickening in the breast or underarm
Changes in breast size, shape appearance
Changes in breast size, shape, or appearance
Skin dimpling or puckering
Nipple discharge or inversion
Redness, swelling, or pain in the breast
Some people may not experience symptoms at all, which is why routine screening is so important.
How diagnosis works
Breast Cancer diagnosis typically begins with a clinical breast exam followed by imaging tests, such as a mammogram, ultrasound, or MRI. If abnormalities are found, a biopsy is performed to confirm the presence of cancer cells. Additional tests, including hormone receptor and HER2 status, help determine the cancer subtype, which guides treatment decisions.
Staging investigations may include CT scans, bone scans, or PET scans to assess whether the cancer has spread. Accurate diagnosis and staging are crucial to selecting the most effective treatment plan.
Types of Breast Cancer
There are several types and subtypes of Breast Cancer, each with different characteristics and treatment approaches:
Invasive ductal carcinoma (IDC): The most common form,
starting in the milk ducts and spreading into nearby tissue
Invasive lobular carcinoma (ILC): Starts in the milk-
producing glands
Ductal carcinoma in situ (DCIS): A non-invasive early form
Triple-negative Breast Cancer (TNBC): Lacks hormone and HER2 receptors, often more aggressive
HER2-positive Breast Cancer: High levels of HER2 protein,
which may respond to targeted drugs
Hormone receptor-positive Breast Cancer: Driven by estrogen and/or progesterone hormones
Understanding the specific type of Breast Cancer is essential for choosing the most effective treatment and trial options.
Treatment options
Breast Cancer treatment is often tailored based on the subtype, stage, and patient preferences. Common treatment approaches include:
Surgery: Lumpectomy or mastectomy to remove the tumor
Radiotherapy: To destroy any remaining cancer cells post-surgery
Chemotherapy: Often used before or after surgery to reduce recurrence
Hormone therapy: For hormone receptor-positive Breast Cancer
Targeted therapy: Such as trastuzumab for HER2-positive cancer
Immunotherapy: Increasingly used in some subtypes, such as triple-negative Breast Cancer
Treatment is usually delivered by a multidisciplinary team and may involve combinations of therapies over several months.
Breast Cancer clinical trials available now
Current studies focus on early-stage disease, metastatic cancer, HER2-positive tumors, TNBC, and hormone-driven cancers. Trials may involve targeted therapy, immunotherapy, cancer vaccines, or new drug combinations. Eligibility varies, which is why personalized matching is essential.
Blog
Related research and insights
Start your Al-powered clinical trial search
New treatment options could be just a click away. Start a chat with CancerBot matched with clinical trials tailored to you-quickly, easily, and at no cost.
Frequently asked questions
Everything else you need to know.
Who qualifies for breast cancer clinical trials?
Eligibility depends on factors like cancer subtype, stage, prior treatments, biomarkers (HER2, ER/PR), age, organ function, and location. CancerBot helps match these factors automatically.
Are trials only for advanced-stage disease?
No. Many studies target early-stage, postoperative, neoadjuvant, or prevention settings. Others focus on metastatic disease or specific subtypes like TNBC or HER2-positive cancer.
Are clinical trials safe?
Trials undergo strict scientific and ethical review. All treatments are monitored for safety, and patients receive close clinical follow-up.
Does it cost money to join a clinical trial?
Trial drugs and study procedures are usually free. Standard care is billed normally.